Research Articles from literature

  1. Cellular uptake of Aib-containing amphipathic helix peptide.
  2. Identification and characterization of a new family of cell penetrating peptides: Cyclic cell penetrating peptides.
  3. Preferential Uptake of L- versus D-Amino Acid Cell-Penetrating Peptides in a Cell Type-Dependent Manner.
  4. Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.
  5. Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E).
  6. Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity.
  7. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
  8. An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.
  9. Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines.
  10. Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice.
  11. Characterization of bioactive cell penetrating peptides from human cytochrome c: protein mimicry and the development of a novel apoptogenic agent.
  12. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
  13. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.
  14. Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region.
  15. A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.
  16. Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin.
  17. Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis.
  18. Synthesis and studies on cell-penetrating peptides.
  19. Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor.
  20. Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.
  21. Identification and characterization of a novel cell-penetrating peptide.
  22. A novel cell-penetrating peptide sequence derived by structural minimization of a snake toxin exhibits preferential nucleolar localization.
  23. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
  24. Predicting cell-penetrating peptides.
  25. Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.
  26. all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study.
  27. A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.
  28. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.
  29. Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain.
  30. Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells.
  31. Characterization of a novel cell penetrating peptide derived from Bag-1 protein.
  32. Structure-activity relationship study of the cell-penetrating peptide pVEC.
  33. A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.
  34. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.
  35. Mechanism of uptake of C105Y, a novel cell-penetrating peptide.
  36. Characterisation of cell-penetrating peptide-mediated peptide delivery.
  37. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.
  38. Structure analysis of the protein transduction domain of human Period1 and its mutant analogs.
  39. Interaction of primary amphipathic cell-penetrating peptides with phospholipid-supported monolayers.
  40. A new peptide with membrane-permeable function derived from human circadian proteins.
  41. Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.
  42. New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.
  43. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.
  44. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein.
  45. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis.
  46. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells.
  47. PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells.
  48. Studies on the internalization mechanism of cationic cell-penetrating peptides.
  49. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells.
  50. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.
  51. Cell membrane translocation of the N-terminal (1-28) part of the prion protein.
  52. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes.
  53. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.
  54. Cellular import mediated by nuclear localization signal Peptide sequences.
  55. Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals.
  56. A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo.
  57. Thrombospondin stimulates focal adhesion disassembly through Gi- and phosphoinositide 3-kinase-dependent ERK activation.
  58. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo.
  59. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
  60. Cellular internalization of a cargo complex with a novel peptide derived from the third helix of the islet-1 homeodomain. Comparison with the penetratin peptide.
  61. Efficient intracellular delivery of GFP by homeodomains of Drosophila Fushi-tarazu and Engrailed proteins.
  62. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors.
  63. Efficient nonviral transfection of dendritic cells and their use for in vivo immunization.
  64. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.
  65. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.
  66. Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides.
  67. Deletion analogues of transportan.
  68. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens.
  69. Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin.
  70. A highly membrane-active peptide in Flock House virus: implications for the mechanism of nodavirus infection.
  71. Structural requirements for cellular uptake of alpha-helical amphipathic peptides.
  72. Extensive cellular uptake into endothelial cells of an amphipathic beta-sheet forming peptide.
  73. Conformations of primary amphipathic carrier peptides in membrane mimicking environments.
  74. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.
  75. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers.
  76. Intercellular trafficking and protein delivery by a herpesvirus structural protein.
  77. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent.
  78. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells.
  79. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence.
  80. Neurotrophic activity of the Antennapedia homeodomain depends on its specific DNA-binding properties.